Clinical Study of Bowel Preparation Before Colonoscopy

• Status: Recruiting
• Trial end date: 2024-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study was a single-center, randomized controlled clinical study. Subjects meeting the inclusion criteria will be randomly assigned to magnesium sodium potassium sulfate oral concentrated solution group, magnesium sodium potassium sulfate oral concentrated solution + linaclotide group, PEG group in equal proportion.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jinling Hospital, China
• Treatments: Interferon-alpha; Interferons; Linaclotide; Magnesium Sulfate; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Signed written informed consent;

• Age 18-80 years old, gender is not limited;

• The subjects could follow the follow-up plan, objectively describe the symptoms, and cooperate with the completion of the scale;

• Non-lactating pregnant women and no pregnancy plan during the test;

• Do not participate in any clinical trials for 3 months before and during the trial;

• Participate voluntarily and sign informed consent.

Exclusion Criteria:

• NYHA cardiac function grade III or IV;

• Unstable angina pectoris in the convalescence period of acute myocardial infarction or in the near future;

• have serious liver and kidney function diseases;

• Suspected gastrointestinal obstruction or gastrointestinal perforation;

• Pregnant or lactating women;

• Mental illness or physical dysfunction can not cooperate with the examination;

• People who are allergic to intestinal preparation drugs.

• Patients who did not undergo colonoscopy after bowel clearing due to their own reasons;

• Patients who can not tolerate general colonoscopy and terminate the examination;

• Patients who requested withdrawal from the study.